Phase II trial of atezolizumab (A) plus carboplatin (C) plus pemetrexed (P) plus bevacizumab (B) in pts with stage IV non-squamous non-small cell lung cancer (NSq-NSCLC): Big Ten Cancer Research Consortium Study LUN 17-139.

被引：3

作者：

Ardeshir-Larijani, Fatemeh

Althouse, Sandra K.

Leal, Ticiana

Feldman, Lawrence Eric

Abu Hejleh, Taher

Patel, Malini

Gentzler, Ryan D.

Miller, Adam Ryan

Hanna, Nasser H.

机构：

[1] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA

[2] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA

[3] Univ Illinois Hosp & Hlth Sci Syst, Chicago, IL USA

[4] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA

[5] Rutgers Canc Inst New Jersey, New Bruswick, NJ USA

[6] Univ Virginia, Ctr Canc, Charlottesville, VA 22908 USA

[7] Indiana Univ Sch Med, Winchester, MA USA

来源：

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.9034

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

9034

引用

页数：2